Fulgent Genetics, Inc. (CIK: 0001674930) EDGAR, Information, Filings... CompaniesBIO.Com

Fulgent Genetics, Inc.

Mailing address
4978 SANTA ANITA AVENUE, SUITE 205, TEMPLE CITY, Delaware, 91780
Phone
626-350-0537
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
Filings
N/A

Fulgent Genetics, Inc. (CIK: 0001674930) is an American company incorporated in the state of California. Head office is located at 4978 SANTA ANITA AVENUE, SUITE 205, TEMPLE CITY, California, 91780. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. Fulgent Genetics, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Fulgent Diagnostics, Inc. from 2016-09-Jun to 2016-15-Jul

Owner	Filings	Transaction Date	Type of Owner
GROVES REGINA E	0001653877	Jan-03-2023	director
POST LEONARD E	0001235862	Aug-01-2022	director
Nohaile Michael	0001890563	Aug-01-2022	director
Ming Hsieh Trust	0001836339	Dec-15-2020	10 percent owner
Xie Jian	0001819718	Aug-03-2020	officer: Chief Operating Officer
Marsh Linda	0001765204	Aug-01-2019	director
Fulgent Genetics, Inc.	0001674930	May-16-2017	director
BOLGER JOHN C	0001183863	Sep-28-2016	director
KIM PAUL	0001253820	Sep-28-2016	officer: CFO and Treasurer
Hsieh Ming	0001302110	Sep-28-2016	director, 10 percent owner, officer: President and CEO
Mulay James	0001684531	Sep-28-2016	director
Gao Hanlin	0001684532	Sep-28-2016	10 percent owner, officer: Chief Scientific Officer
Yen Yun	0001684584	Sep-28-2016	director
Xi Long USA, Inc.	0001684591	Sep-28-2016	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Fulgent Genetics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SCHEDULE 13G	Document	Acc-no: 0001104659-25-002018 (34 Act) Size: KB	Jan-08-2025	005-89656 25518496
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-133315 ( Act) Size: 0 KB	Dec-04-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-133311 ( Act) Size: 0 KB	Dec-04-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-133308 ( Act) Size: 0 KB	Dec-04-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0000950170-24-132391 (33 Act) Size: 0 KB	Dec-02-2024	001-37894 241520538
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0000950170-24-132390 (33 Act) Size: 0 KB	Dec-02-2024	001-37894 241520536
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-131593 ( Act) Size: 0 KB	Nov-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-131595 ( Act) Size: 0 KB	Nov-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-131592 ( Act) Size: 0 KB	Nov-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-131590 ( Act) Size: 0 KB	Nov-27-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0000950170-24-130694 (33 Act) Size: 0 KB	Nov-25-2024	001-37894 241497764
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0000950170-24-130693 (33 Act) Size: 0 KB	Nov-25-2024	001-37894 241497763
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0000950170-24-130692 (33 Act) Size: 0 KB	Nov-25-2024	001-37894 241497762
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-123684 (34 Act) Size: KB	Nov-08-2024	001-37894 241437993
8-K	Document	Current report filing Acc-no: 0000950170-24-123681 (34 Act) Size: KB	Nov-08-2024	001-37894 241437982
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950170-24-121578 (34 Act) Size: KB	Nov-05-2024	005-89656 241428210
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-121569 ( Act) Size: 0 KB	Nov-05-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-120110 ( Act) Size: 0 KB	Nov-01-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-118288 ( Act) Size: 0 KB	Oct-29-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-118287 ( Act) Size: 0 KB	Oct-29-2024

Recent 20 filings. View all Fulgent Genetics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Fulgent Genetics, Inc. overview
Fulgent Genetics, Inc. job
Fulgent Genetics, Inc. stock
Fulgent Genetics, Inc. ownership
Fulgent Genetics, Inc. CEO
Fulgent Genetics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.